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A  young  male  patient  recently  diagnosed  with  HIV  presented  to  us  with  a  septic  
tibia.  He developed recurrent seizures and hypoglycaemia.  Terminally  he  developed  
a  clinical  picture  of  Addison’s  crisis  and  disseminated  intravascular  coagulation.  
Addison’s  crisis  must  always be  borne  in  mind  in  patients  with  HIV  who  are  




It  is  estimated  that  the  number  of  people  with  HIV  worldwide  is  33.2  million1.  HIV 
is a serious health issue, particularly in developing countries. There  is  great  controversy  
whether  HIV  per  se  predisposes  to  higher  incidence  of  post  -  operative  infection2,3,4,5.   
Serious  musculo-skeletal  infection  occurs  in  advanced   or  WHO  stage  3   disease. 
Seizures  can  be  the  presenting  symptoms  in  2-  20%  of  HIV-positive  patients.1  The  
cause  can  be  infective  or  non-infective.  Hypoglycaemia can be due to drugs, metabolic or 
hormonal disturbances. We  report  on  a  HIV  -  positive  patient  who  developed  recurrent  
hypoglycaemia,  seizures  and  Addison’s  crisis  during  treatment  for  a  septic  united  tibia.   
 
Case Report     
 
A  43  year-old  male  presented  to  the  orthopaedic  trauma  unit  with  a  clinical  problem  
of  septic  united  tibia.  He had intramedullary nail three years ago.  He was recently 
diagnosed with HIV.  The  CD4  count  was  78x106/litre  and  he  was  not  on  anti-retroviral  
treatment.  Clinically he looked well.  He was apyrexial.  The only clinically relevant findings 
were cervical lymphadenopathy.   
  
The  nail  was  removed  and  reaming  sent  for  microscopy,  culture  and  sensitivity.  
Culture  results  isolated  Proteus  Mirabilis  and  Streptococcus  pyogenes  sensitive  to  
cloxacillin,  ampicillin  and  bactrim (trimethoprim  plus  sulphamethoxazole).  Intravenous  
treatment  was  started  with  the   first  two  drugs  and  continued  for  35  days.  Oral  
therapy  with  bactrim  (160mg  trimethoprim  + 800mg  sulphamethoxazole)   two  tablets  
twice  daily  for  four  days  was  commenced. 
 
A  day  after  stopping  oral  therapy  with  bactrim,  he  developed  hypoglycaemia  with  a  
blood  glucose of  1.6 mmol/l  (normal = 4.1- 59  mmol/l)  and  coma.  He  was  resuscitated  
with  50%  dextrose  intravenously  and  the  infusion  continued  with  10%  dextrose  -  
normal  saline.  Eight hours later he developed generalizedtonic clonic seizures.  Blood 
glucose level was 2.4 mmol/l.  Resuscitation was done using the same regime as before.  The  
following  morning,  approximately  five  hours  later,  he  had  a  second  generalized  tonic  
clonic  seizures  which  lasted  a  minute.  The glucose level was normal.  His clinical 
condition stabilized.  The  last  episode  of  hypoglycaemia  ( blood  glucose  =  1,1  mmol/l  )  
with  no  convulsions  occurred  four  hours  later,  was  accompanied  by  low  blood  
pressure (90/60  mmHg)  and  hypoventilation.  The third seizure occurred  six hours  later. 
  
Table 1. Laboratory Data 
 





Test Normal values 22/8/8 5/9/8 17/9/8 2/10/8 2/10/8 
RCC 4.89-6.11 x 10 12/l 3,56   2,71  
HB 14.3-18.3 g/dl 9,0   6,4  
HCT 0.43-0.55 l/l 0,287   0,186  
MCV 79.1-98.9 fl 80,6   68  
MCH 27.0-32.0 pg 25,3   23  
MCHC 32.0-36.0 g/dl 31,4   34  
RCDW 11.6-14.0 % 15,4%   18 %  
PLT 137-373 x 109/l 222   80  
WCC 4.0-11.0 x 109/l 3,11   2,12  
NEUT  57 %     
LYMP  19 %     
MONO  22,5%     
EOSIN  0,6 %     
BASO  0,3 %     
NA 135-147 mmol/l 131 133 131 128 120 
K 3.3-5.3 mmol/l 3,8 3,1 3,2 5,1 5,4 
CL 99-113 mmol/l  94 93 88 83 
UREA 2.6-7.0 mmol/l 4,1 3,9 5,2 40 39 
CREAT 60-120 ųmol/l 79 66 117 734 677 
AG 7-17 mmol/l  16  30  
CRP 0-10 mg/l 83,3   279  
CD4 500-2010 x 106/l    2  
PT 10-14 seconds    21  
INR 0.9 -1,2    1,74  
PTT 26-36 seconds    60  
Abbreviation: 
RCC = Red  cell  count,  HB = Haemoglobin,  HCT = Haematocrit,  MCV = Mean  corpuscular  volume,  MCH 
= Mean  corpuscular  haemoglobin,  MCHC =  Mean  corpuscular  haemoglobin  concentration,  RCDW = Red  
cell  distribution  width; PLT = Platelets,  WCC = White  cell  count,   NEUT = Neutrophil,  LYMP = 
Lymphocytes,  MONO = Monocytes,  EOSIN = Eosinophils,  BASO = Basophils,  NA = Sodium,  K = 
Potassium,  CL = Chloride,  CREAT = Creatinine,  AG = Anion gap,  CRP = C-reactive  protein,  PT = 
Prothrombin  time,  INR = International  normalized  ratio,  PTT = partial  thromboplastin  time  
 
 Three  hours  after  the   hypoglycaemia  and  shock  he  developed  generalized  seizures  and  severe  
hypoglycaemia  (  blood glucose = 0.6  mmol/l).  The  final  hypoglycaemic  episode  ( blood  glucose 
= 0,9 mmol/l)occurred  an  hour  later.  Resuscitation was unsuccessful.  The  blood  results  show  a  
picture  of  Addisonian  crisis  plus  disseminated  intravascular  coagulation.  Laboratory data and 




Recurrent  hypoglycaemia  in  this  patient  could  be  due  to  either  cotrimoxazole  therapy  or  
Addisonian  crisis.  Seizures  could  be  due  to  metabolic  ( hypoglycaemia)  or  infective  causes.  
Cerebral  infection  was  unlikely  because  the  patient  recovered  well  between  episodes  of  
seizures.  He had no  evidence  of  neurological deficit.  Addisonian  crisis  showed  a  full-blown  
picture  in  the  terminal  stage:  hypotension,  hyperkalaemia,   hyponatraemia  and  hypoglycaemia.   
 
Cotrimoxazole is known  to  cause  hypoglycaemia.  Hypoglycaemia  may  be   prolonged:  lasting  
for  more  than  12  hours.6  The  drug  can  induce  demand-related  or  over-use  hypoglycaemia.6  
Patients  at  risk  are  those  with  renal  failure. 
  
Subclinical  adrenal  dysfunction  is  common  in  HIV-positive  patients.7  Patients  have  marginal  
adrenal  reserves.8,9  Clinically  significant  adrenal  insufficiency  is  not  common.9  Adrenal  failure  
is  the  most  serious  complication  in  these  patients.  It  is  not  clear  from  the  literature  whether  
adrenal  insufficiency  should  always  be  excluded  in  patients  with  HIV,  especially  if  they  are  
 




subjected  to  stress;  like  surgery.  Mohsin  Saley  Eledrisi  et  al.8  state  that identification  of  




1. Satishchandra  P,  Sinha  S.  Seizures  in  HIV-seropositive  individuals:  NIMHANS  
experience  and  review.  Epilepsia  2008;  49  (suppl.  6):  33-41 
2. Bahebeck  J,  Bedimo  R,  Eyenga  V,  et  al.  The  management  of   musculoskeletal  
infection  in  HIV  carriers.  Acta  Orthop. Belg  2004;  70:  355-360 
3. Harrison  WJ,  Lavy  CBD,  Lewis  CP.  One-year  follow-up  of   orthopaedic  implants  in  
HIV-positive  patients.  Int  Orthop  2004;  28:  329-332  
4. Rowley  DI,  Clift  BA,  Sripada  S.  Surgery  in  infectious  diseases.  Current Orthop  2004;  
18:  371-378 
5. O’Brien  ED,  Denton  JR.  Open  tibial  fracture  infections  in  asymptomatic  HIV  antibody  
positive  patients.  Orthop Review  1994;  662-664 
6. Strevel  EL,  Kuper  A,  Gold  WL.  Severe  and  protracted  hypoglycaemia  associated  with  
co-trimoxazole  use.  Lancet  Infect  Dis  2006;  6:  178-182 
7. Mayo  J,  Collazos  J,  Martinez  E,  Ibarra  S.  Adrenal  function  in  the  human  
immunodeficiency  virus-infected  patient.  Arch Intern Med  2002;  162:  1095-1098 
8. Eledrisi  MS,  Verghese  AC.  Adrenal  insufficiency  in  HIV  infection:  A  review  and  
recommendations.  Am  J  Med  Sci  2001;  321:  137-144 
9. Findling  JW,  Buggy  BP,  Gilson  IH,  Brummit  CF,  Bernstein  BM,  Raff  H.  Longitudinal  
evaluation  of  adrenocortical  function  in  patients  with  the  human  immunodeficiency  
virus.  J  Clin  Endocrinol  Metab  1994;  79:  1091-1096 
 
 
